These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24482151)

  • 1. Cholinesterase inhibitors should not be prescribed for mild cognitive impairment.
    Russ TC
    Evid Based Med; 2014 Jun; 19(3):101. PubMed ID: 24482151
    [No Abstract]   [Full Text] [Related]  

  • 2. Donepezil abolishes anticholinergic activity in a patient with amnesia.
    Konishi K; Hori K; Tomioka H; Minegishi G; Tani M; Tanaka H; Akita R; Yokoyama S; Oshio T; Hachisu M
    Pharmacology; 2013; 91(1-2):86-91. PubMed ID: 23258422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of Cognitive Treatments Administered to Patients Affected by Mild Cognitive Impairment/Mild Neurocognitive Disorder.
    Cavallo M; Signorino A; Perucchini ML
    Drug Dev Res; 2016 Dec; 77(8):444-452. PubMed ID: 27569987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Psychopharmacology (Berl); 2016 Apr; 233(7):1235-43. PubMed ID: 26769042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of mild cognitive disorders].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):121-5. PubMed ID: 24596976
    [No Abstract]   [Full Text] [Related]  

  • 6. AD: are we intervening too late?
    Korczyn AD
    J Neural Transm (Vienna); 2011 Sep; 118(9):1359. PubMed ID: 21863300
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].
    Gavrilova SI; Fedorova IaB; Gantman ; Kalyn IaB; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):16-20. PubMed ID: 22433803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB
    CNS Drugs; 2017 Sep; 31(9):759-776. PubMed ID: 28786085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comment on the paper by A. Valikovics et al. "The effect of vinpocetin on cognitive function" published in the issue 3-4 of this year].
    Gyuris J
    Ideggyogy Sz; 2012 May; 65(5-6):215. PubMed ID: 22724292
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive impairment in nondemented Parkinson's disease.
    Barone P; Aarsland D; Burn D; Emre M; Kulisevsky J; Weintraub D
    Mov Disord; 2011 Dec; 26(14):2483-95. PubMed ID: 22170275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil Monotherapy for Neurocognitive Deficits and Psychobehavioral Disinhibition in an Adolescent Posttraumatic Brain Injury.
    Naguy A
    Am J Ther; 2018; 25(5):e593-e595. PubMed ID: 29901470
    [No Abstract]   [Full Text] [Related]  

  • 12. Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Koola MM; Sklar J; Davis W; Nikiforuk A; Meissen JK; Sawant-Basak A; Aaronson ST; Kozak R
    Schizophr Res; 2018 Mar; 193():459-460. PubMed ID: 28705532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L
    Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial.
    Lin CH; Chen PK; Chang YC; Chuo LJ; Chen YS; Tsai GE; Lane HY
    Biol Psychiatry; 2014 May; 75(9):678-85. PubMed ID: 24074637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of some acridine-piperazine hybrids for the improvement of cognitive dysfunction.
    Sharma A; Piplani P
    Chem Biol Drug Des; 2017 Nov; 90(5):926-935. PubMed ID: 28544619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.
    Teipel SJ; Cavedo E; Grothe MJ; Lista S; Galluzzi S; Colliot O; Chupin M; Bakardjian H; Dormont D; Dubois B; Hampel H;
    Neuropharmacology; 2016 Sep; 108():128-35. PubMed ID: 26876309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New lignans attenuating cognitive deterioration of Aβ transgenic flies discovered in Acorus tatarinowii.
    Zhang WY; Feng XL; Lu D; Gao H; Yu Y; Yao XS
    Bioorg Med Chem Lett; 2018 Feb; 28(4):814-819. PubMed ID: 29307497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Matsunaga S; Kishi T; Annas P; Basun H; Hampel H; Iwata N
    J Alzheimers Dis; 2015; 48(2):403-10. PubMed ID: 26402004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer's disease--treatment with and without drugs].
    Wolter DK
    MMW Fortschr Med; 2012 Apr; 154(7):85-7, 89-90. PubMed ID: 22558882
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effects of Bushen Capsule on Episodic Memory in Amnestic Mild Cognitive Impairment Patients: A Pilot Placebo Controlled fMRI Study.
    Zhang J; Xu K; Wei D; Guo R; Li H; Wang Y; Zhang Z
    J Alzheimers Dis; 2015; 46(3):665-76. PubMed ID: 25854932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.